| [1] |
CONVILLE P S, BROWN-ELLIOTT B A, SMITH T, et al. The complexities of Nocardia taxonomy and identification[J]. J Clin Microbiol, 2017, 56(1):e01419-17.
|
| [2] |
LYNCH J P 3rd, REID G, CLARK N M. Nocardia spp.:a rare cause of pneumonia globally[J]. Semin Respir Crit Care Med, 2020, 41(4):538-554.
DOI
URL
|
| [3] |
陈荣忠, 张杰斯, 向蓉. 脓液诺卡菌肺部感染1例[J]. 中华结核和呼吸杂志, 2022, 45(6):584-587.
|
| [4] |
SERINO M, SOUSA C, REDONDO M, et al. Nocardia spp. isolation in chronic lung diseases:are there differences between patients with pulmonary nocardiosis and Nocardia colonization?[J]. J Appl Microbiol, 2022, 133(5):3239-3249.
DOI
URL
|
| [5] |
RASHEED M U, BELAY G. Nocardiosis in HIV seropositive clinically suspected pulmonary tuberculosis patients[J]. Trop Doct, 2008, 38(1):34-35.
DOI
PMID
|
| [6] |
MEHRABADI S M, TARAGHIAN M, PIROUZI A, et al. Pulmonary nocardiosis in suspected tuberculosis patients:a systematic review and meta-analysis of cross-sectional studies[J]. Ethiop J Health Sci, 2020, 30(2):293-300.
|
| [7] |
林振山, 王小智. 肺诺卡菌病误诊肺结核1例并文献复习[J]. 传染病信息, 2023, 36(3):280-283.
|
| [8] |
ÖLMEZ S, OTLU B, ŞENER B, et al. The importance of gram-stained smears in the diagnosis of Nocardia infections[J]. Mikrobiyol Bul, 2023, 57(1):108-118.
DOI
URL
|
| [9] |
CONVILLE P S, BROWN J M, STEIGERWALT A G, et al. Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov.,human pathogens and members of the "Nocardia transvalensis complex"[J]. J Clin Microbiol, 2008, 46(4):1178-1184.
|
| [10] |
TOYOKAWA M, TANIGUCHI M, UESAKA K, et al. Complete genome sequence of multidrug-resistant strain Nocardia wallacei FMUON74,isolated from a sputum culture[J]. Microbiol Resour Announc, 2020, 9(47):e01022-20.
|
| [11] |
MCNEIL M M, BROWN J M, GEORGHIOU P R, et al. Infections due to Nocardia transvalensis:clinical spectrum and antimicrobial therapy[J]. Clin Infect Dis, 1992, 15(3):453-463.
DOI
URL
|
| [12] |
DIALLO A, DEMBELE Y, YAYA I, et al. Disseminated Nocardia transvalensis complex and farcinica:first case in an immunocompetent[J]. New Microbes New Infect, 2023,53:101148.
|
| [13] |
WALLACE R J Jr, SEPTIMUS E J, WILLIAMS T W Jr, et al. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia[J]. Rev Infect Dis, 1982, 4(2):315-325.
DOI
URL
|
| [14] |
TAN Y E, CHEN S C, HALLIDAY C L. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species:results from a large tertiary laboratory in Australia[J]. J Glob Antimicrob Resist, 2020,20:110-117.
|
| [15] |
WANG H, ZHU Y, CUI Q, et al. Epidemiology and antimicrobial resistance profiles of the Nocardia species in China,2009 to 2021[J]. Microbiol Spectr, 2022, 10(2):e0156021.
DOI
URL
|
| [16] |
O'BRIEN A, HART J, HIGGINS A, et al. Nocardia species distribution and antimicrobial susceptibility within Australia[J]. Intern Med J, 2024, 54(4):613-619.
DOI
URL
|
| [17] |
Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing of Mycobacteria, Nocardia spp., and other Aerobic actinomycetes.1st ed[S]. M62,CLSI, 2018.
|
| [18] |
国家卫生健康委合理用药专家委员会. 国家抗微生物治疗指南(第3版)[M]. 北京: 人民卫生出版社, 2023.
|
